.gif)
OSTEOARTHRITIS
Intra-articular sodium hyaluronate vs placebo over 6 month follow-up in knee OA treatment
Rheumatology (Oxford). 1999 Jul;38(7):602-7.100 patients with persistent mild to moderate osteoarthritis of the knee were randomized to receive intra-articular injections of either sodium hyaluronate (Hyalgan) or saline placebo. The purpose of this study was to compare pain and function, primarily, as well as patient global assessment, patient satisfaction and development of adverse effects between groups. Results of the primary end points demonstrated significant lower pain in the HA group over 6 month, and better functional outcome over 2 month follow-up, but not 6 month follow-up. Incidence of adverse events was similar between groups, though two sever adverse events in the HA group were considered related to treatment, while no adverse events in the placebo group were deemed related to treatment.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
